Singapore markets closed

Walvax Biotechnology Co., Ltd. (300142.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
13.99-0.34 (-2.37%)
At close: 03:04PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,880,259
4,113,772
5,086,445
3,462,831
2,939,021
Cost of revenue
586,228
597,556
609,469
394,339
399,810
Gross profit
3,294,031
3,516,216
4,476,976
3,068,492
2,539,212
Operating expenses
Research development
684,538
776,425
932,895
621,493
176,493
Selling general and administrative
1,524,954
1,615,980
2,125,742
1,490,929
1,265,041
Total operating expenses
2,330,689
2,493,620
3,145,221
2,202,002
1,517,849
Operating income or loss
963,341
1,022,596
1,331,756
866,490
1,021,363
Interest expense
8,052
5,949
7,107
5,771
597.4875
Income before tax
445,498
598,976
1,070,465
708,945
1,373,304
Income tax expense
94,164
87,651
132,239
107,593
162,117
Income from continuing operations
351,333
511,325
938,226
601,352
1,211,187
Net income
261,527
419,390
728,652
427,748
1,003,187
Net income available to common shareholders
261,527
419,390
728,652
427,748
1,003,187
Basic EPS
0.46
0.26
0.45
0.27
0.65
Diluted EPS
0.46
0.26
0.45
0.27
0.64
Basic average shares
1,622,877
1,600,115
1,602,842
1,568,565
1,539,102
Diluted average shares
1,622,877
1,600,115
1,603,548
1,573,180
1,559,196